Abstracts

1108 – Retention Trajectories in HIV Care Are Partially Patterned by Chronic Comorbidities in North America

Background Sustained retention in HIV care is critical for viral suppression and epidemic control, yet sources of heterogeneity in longitudinal care engagement, like clinical complexity and chronic comorbidity management, remain underexplored. Using a standard retention metric, we employed latent class analysis to describe retention trajectories and associated clinical profiles among people with HIV (PWH) in…

275 – Stem-Like CD8 T Cells Replenish Durable HIV-Specific Effector Responses After ATI

Background Mechanisms underlying lasting HIV control in a subset of individuals with following analytical treatment interruption (ATI) remain undefined. We and others have shown that durable HIV control is associated with stem-like CD8 T cells that promote long-lived polyfunctional effector populations. Ex vivo disruption of CCR5 in autologous T cells led to partial post-ATI control in…

512 – Dolutegravir Exposure Testing Accurately Targets Integrase Resistance and Reduces Monitoring Costs

Background DTG resistance is increasingly reported among treatment-experienced people with HIV in low- and middle-income countries. Because most viremia on DTG reflects adherence lapses rather than resistance, guidelines restrict testing to prolonged viraemia, often delaying detection of resistance. We evaluated a laboratory-initiated reflex strategy using plasma DTG exposure to guide resistance testing in routine care. Methods We…

311 – Dasatinib Enhances NK-Cell Cytotoxicity and Effector Function in ART-Suppressed People With HIV

Background Dasatinib, a tyrosine kinase inhibitor approved for chronic myeloid leukemia, has been shown to modulate immune responses and promote NK cell expansion and cytotoxicity. NK cells are critical effectors of innate immunity with the capacity to eliminate HIV-infected CD4⁺ T cells, but their function is often impaired under long-term ART. As viral persistence in…

316 – Divergent Systemic and Mucosal SARS-CoV-2 Adaptive Immunity in African Adults Without HIV

Background The upper (URT) and lower (LRT) respiratory tracts are the principal sites of SARS-CoV-2 infection and severe COVID-19 disease, respectively. While serum anti-Spike antibody levels are associated with a reduced risk of reinfection, the mechanistic correlates of airway protection remain unclear. Methods In this prospective cohort study, we recruited HIV-uninfected, COVID-19–unvaccinated adults in Blantyre,…

1061 – Oral PrEP Uptake and Continuation in Mozambique: Findings From Large Scale Implementation

Background Access to HIV pre-exposure prophylaxis (PrEP) has expanded significantly in resource-limited settings, including Mozambique, where oral PrEP was implemented at select health facilities in 2017, and nationally in 2021. Understanding patterns of oral PrEP uptake and persistence is essential to inform relevant strategies. Methods We conducted a mixed-methods evaluation to assess uptake and continuation…

915 – Neighborhood Deprivation and HIV Retention-in-Care in a Southern Metropolitan Setting

Background The environment in which people with HIV (PWH) reside plays a complex and influential role in shaping outcomes along the HIV Care Continuum. In this study, we investigated the Area Deprivation Index (ADI)—a comprehensive metric of neighborhood-level disadvantage which ranks geographic areas based on cumulative socioeconomic adversity—as a potential determinant of retention-in-care (RiC) among…